Megaphone Eyewire headlines are now available as a weekly podcast! Listen Now

Menu dropdown menu Search search

Eyewire News

Featured Story

Harrow Launches HarrowRx Prescribing Platform to Streamline Ophthalmic Medication Access image

11.03.2026

Harrow Launches HarrowRx Prescribing Platform to Streamline Ophthalmic Medication Access

Latest News Stories

AEYE Health Wins 2026 Prix Galien USA Award for Autonomous AI Diabetic Retinopathy Screening Technology image

11.04.2026

AEYE Health Wins 2026 Prix Galien USA Award for Autonomous AI Diabetic Retinopathy Screening Technology
Newton Launches Newton Preferred Membership Program for Independent Eye Care Practices image

11.04.2026

Newton Launches Newton Preferred Membership Program for Independent Eye Care Practices
Zeiss Commits to Expanding Global Eye Care Access at IAPB Summit image

11.03.2026

Zeiss Commits to Expanding Global Eye Care Access at IAPB Summit
Moorfields Eye Hospital Appoints Aruna Mehta as New Chair image

11.03.2026

Moorfields Eye Hospital Appoints Aruna Mehta as New Chair
Z Optics Expands Z+ Virtual Aperture IOL Clinical Trial to Canada image

11.03.2026

Z Optics Expands Z+ Virtual Aperture IOL Clinical Trial to Canada
Hundred Vision Launches Luma Eye-Tracking System to Assess Oculomotor and Binocular Visual Function image

11.02.2026

Hundred Vision Launches Luma Eye-Tracking System to Assess Oculomotor and Binocular Visual Function
Johnson & Johnson Announces Global Commitment to Expand Access to Eye Care and Prevent Vision Loss image

11.02.2026

Johnson & Johnson Announces Global Commitment to Expand Access to Eye Care and Prevent Vision Loss
Eyedaptic Launches AI-Powered Visual Assistant for EYE7 Smart Glasses image

11.02.2026

Eyedaptic Launches AI-Powered Visual Assistant for EYE7 Smart Glasses

11.02.2026

FDA Approves Lucamzi as Ranibizumab Biosimilar for Retinal Diseases
OpZira Completes Stage II Audit for AdaptDx Pro, Advances Plans for European CE Marking image

11.02.2026

OpZira Completes Stage II Audit for AdaptDx Pro, Advances Plans for European CE Marking
Okogen Doses First Patient in Phase 1/2 EMERALD Trial of Treyegen for Acute Infectious Conjunctivitis image

11.02.2026

Okogen Doses First Patient in Phase 1/2 EMERALD Trial of Treyegen for Acute Infectious Conjunctivitis
Octant Receives FDA Orphan Drug Designation for OCT-980 for the Treatment of Retinitis Pigmentosa image

10.30.2026

Octant Receives FDA Orphan Drug Designation for OCT-980 for the Treatment of Retinitis Pigmentosa
VisioSurgical Solutions Launches, Starts Development of Compact Surgical Robot for Retinal Surgery image

10.30.2026

VisioSurgical Solutions Begins Development of Compact Surgical Robot for Retinal Surgery
Lenz Therapeutics Announces Major Restructuring and CEO Transition image

10.30.2026

Lenz Therapeutics Announces Major Restructuring and CEO Transition
Oculis to Present Privosegtor Data at Upcoming Ophthalmology and Neurology Conferences image

10.29.2026

Oculis to Present Privosegtor Data at Upcoming Ophthalmology and Neurology Conferences
Kiora Plans Phase 3 CRAO and Phase 2b NAION Trials of KIO-401 image

10.29.2026

Kiora Plans Multinational Phase 3 CRAO and Phase 2b NAION Trials of KIO-401

10.29.2026

Tarsus Pharmaceuticals Names Neera Clase as CCO

10.28.2026

Centre for Sight Founder Sheraz Daya, MD, Receives AAO Lifetime Achievement Honor Award

10.28.2026

Nacuity Pharmaceuticals Doses First Patient in Phase 3 Trial of NPI-001 for the Treatment of RP Associated with Usher Syndrome

View More

EyewireTV

Eyewire TV October 28, 2026 thumbnail

Stay Updated

Sign up for Eyewire News and EyewireTV e‑newsletters to stay up to date on news in eye care!

Subscribe right arrow